AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35490744 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 33332538 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized aerobic exercise program (B-FIT), 4-month duration, 2 low-intensity sessions and 1 high-intensity session per week
Number of subjects: 31
Study 33332538 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized aerobic exercise program (B-FIT)
Number of subjects: 31
Study 35781692 — intervention group
Group type: COMPARATOR
Intervention: Connective Tissue Graft (CTG)
Number of subjects: 60
Study 35781692 — intervention group
Group type: EXPERIMENTAL
Intervention: Collagen Matrix (CMX)
Number of subjects: 60
Study 33497465 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-sampling (SS arm)
Number of subjects: 11951
Study 33497465 — intervention group
Group type: COMPARATOR
Intervention: Sampling by medical professionals (SMP arm)
Number of subjects: 11951
Study 32725069 — intervention group
Group type: EXPERIMENTAL
Intervention: Fungicide treatment FT1 (pyraclostrobin + fluxapyroxad)
Number of subjects: 4
Study 32725069 — intervention group
Group type: EXPERIMENTAL
Intervention: Fungicide treatment FT2 (trifloxystrobin + prothioconazole)
Number of subjects: 4
Study 32725069 — intervention group
Group type: EXPERIMENTAL
Intervention: Cultivar FM 975
Number of subjects: 4
Study 32725069 — intervention group
Group type: EXPERIMENTAL
Intervention: Shorter plants (1 m)
Number of subjects: 4
Study 32725069 — intervention group
Group type: EXPERIMENTAL
Intervention: Cultivar FM 944
Number of subjects: 4
Study 32725069 — intervention group
Group type: COMPARATOR
Intervention: Control (no fungicide)
Number of subjects: 4
Study 34333889 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided Self-Determination (GSD) intervention with weekly sessions for eight weeks
Number of subjects: 200
Study 34333889 — intervention group
Group type: COMPARATOR
Intervention: Control group (regular visits to the pain centre with doctors and nurses)
Number of subjects: 200
Study 34333889 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided Self-Determination (GSD) intervention
Number of subjects: 200
Study 34333889 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 200
Study 32572779 — intervention group
Group type: EXPERIMENTAL
Intervention: Electro-acupuncture (EA)
Number of subjects: 76
Study 32572779 — intervention group
Group type: COMPARATOR
Intervention: Control (pseudo-acupuncture)
Number of subjects: 76
Study 35813843 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (3 mg/kg/b.m.)
Number of subjects: 13
Study 33620417 — intervention group
Group type: EXPERIMENTAL
Intervention: Layperson-delivered, empathy-focused program of telephone calls
Number of subjects: 240
Study 33620417 — intervention group
Group type: COMPARATOR
Intervention: No calls (control group)
Number of subjects: 240
Study 32133542 — intervention group
Group type: EXPERIMENTAL
Intervention: Liman applications, bath, and heliotherapy (group 1)
Number of subjects: 91
Study 32133542 — intervention group
Group type: COMPARATOR
Intervention: Mud-bath therapy using clay peloid mixed with tap water and heliotherapy (group 2)
Number of subjects: 91
Study 35171145 — intervention group
Group type: EXPERIMENTAL
Intervention: Penetrating femtosecond laser corneal relaxing incisions (8 mm optical zone)
Number of subjects: 248
Study 35171145 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrastromal femtosecond laser corneal relaxing incisions (8 mm optical zone)
Number of subjects: 248
Study 35171145 — intervention group
Group type: EXPERIMENTAL
Intervention: 9 mm penetrating femtosecond laser corneal relaxing incisions
Number of subjects: 248
Study 35171145 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 248
Study 34587106 — intervention group
Group type: EXPERIMENTAL
Intervention: One hand used for trajectory-tracking tasks
Number of subjects: 18
Study 34587106 — intervention group
Group type: EXPERIMENTAL
Intervention: Other hand used for trajectory-tracking tasks
Number of subjects: 18
Study 34587106 — intervention group
Group type: EXPERIMENTAL
Intervention: Adaptation to reject disturbances (exogenously applied by the experimenter)
Number of subjects: 18
Study 34587106 — intervention group
Group type: EXPERIMENTAL
Intervention: Adaptation to reject disturbances (endogenously generated by sensorimotor noise)
Number of subjects: 18
Study 32382043 — intervention group
Group type: EXPERIMENTAL
Intervention: SRI
Number of subjects: 182
Study 32382043 — intervention group
Group type: COMPARATOR
Intervention: IUI
Number of subjects: 182
Study 35538143 — intervention group
Group type: EXPERIMENTAL
Intervention: anthracycline/taxane‐based NACT plus metformin
Number of subjects: 80
Study 32439227 — intervention group
Group type: EXPERIMENTAL
Intervention: Haloperidol 2 mg
Number of subjects: 0
Study 32439227 — intervention group
Group type: EXPERIMENTAL
Intervention: Haloperidol 3 mg
Number of subjects: 0
Study 32439227 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 35725488 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-dose Ebola vaccine regimen (Ad26.ZEBOV, MVA-BN-Filo)
Number of subjects: 2000
Study 35725488 — intervention group
Group type: COMPARATOR
Intervention: Control (unvaccinated pregnant women)
Number of subjects: 2000
Study 32178279 — intervention group
Group type: EXPERIMENTAL
Intervention: EPA-rich fish oil (12 g/day, EPA/DHA: 2.3)
Number of subjects: 30
Study 32178279 — intervention group
Group type: EXPERIMENTAL
Intervention: DHA-rich fish oil (12 g/day, EPA/DHA: 0.3)
Number of subjects: 30
Study 35398293 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily teriparatide (20 μg)
Number of subjects: 131
Study 35398293 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly high-dose teriparatide (56.5 μg)
Number of subjects: 131
Study 35398293 — intervention group
Group type: COMPARATOR
Intervention: Bisphosphonates (BPs)
Number of subjects: 131
Study 32799967 — intervention group
Group type: EXPERIMENTAL
Intervention: GUMLi EAT FFQ
Number of subjects: 97
Study 32495208 — intervention group
Group type: EXPERIMENTAL
Intervention: High density screw constructs (> 1.8 screws per level fused)
Number of subjects: 159
Study 32495208 — intervention group
Group type: COMPARATOR
Intervention: Low density screw constructs (< 1.4 screws per level fused)
Number of subjects: 159
Study 32495208 — intervention group
Group type: EXPERIMENTAL
Intervention: Understanding of the trial
Number of subjects: 159
Study 35287618 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 g of tranexamic acid (TXA) 15 minutes before surgery
Number of subjects: 160
Study 35287618 — intervention group
Group type: COMPARATOR
Intervention: Placebo 15 minutes before surgery
Number of subjects: 160
Study 35287618 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 160
Study 33577729 — intervention group
Group type: EXPERIMENTAL
Intervention: Enfortumab vedotin (1.25 mg/kg on days 1, 8, and 15 of a 28-day cycle)
Number of subjects: 608
Study 33577729 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy (investigator-chosen standard docetaxel, paclitaxel, or vinflunine on day 1 of a 21-day cycle)
Number of subjects: 608
Study 33577729 — intervention group
Group type: EXPERIMENTAL
Intervention: Enfortumab vedotin
Number of subjects: 608
Study 33577729 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy
Number of subjects: 608
Study 34173699 — intervention group
Group type: EXPERIMENTAL
Intervention: Bioresorbable vascular scaffolds (BVS)
Number of subjects: 240
Study 34173699 — intervention group
Group type: COMPARATOR
Intervention: Everolimus-eluting stents (EES) / Biolimus-eluting stents (BES)
Number of subjects: 240
Study 32064967 — intervention group
Group type: EXPERIMENTAL
Intervention: Endometrial Myomectomy (EM)
Number of subjects: 360
Study 32064967 — intervention group
Group type: EXPERIMENTAL
Intervention: Subserosal Myomectomy (SM)
Number of subjects: 360
Study 32064967 — intervention group
Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 360
Study 35691596 — intervention group
Group type: EXPERIMENTAL
Intervention: EGCG intervention
Number of subjects: 0
Study 34215870 — intervention group
Group type: EXPERIMENTAL
Intervention: Trastuzumab emtansine
Number of subjects: 330
Study 34215870 — intervention group
Group type: COMPARATOR
Intervention: Trastuzumab, pertuzumab and docetaxel
Number of subjects: 330
Study 34989067 — intervention group
Group type: EXPERIMENTAL
Intervention: Messages about vaccination coverage rates (varied between 10% and 95%)
Number of subjects: 1365
Study 34989067 — intervention group
Group type: EXPERIMENTAL
Intervention: Messages about vaccination coverage rates (up to 75%)
Number of subjects: 1365
Study 34989067 — intervention group
Group type: EXPERIMENTAL
Intervention: Messages about vaccination coverage rates (above 75%)
Number of subjects: 1365
Study 34989067 — intervention group
Group type: COMPARATOR
Intervention: Control group with no message
Number of subjects: 1365
Study 33691075 — intervention group
Group type: EXPERIMENTAL
Intervention: EasyMICI–MaMICI® telemedicine platform
Number of subjects: 54
Study 33691075 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 54
Study 34898001 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-led supportive-expressive group intervention
Number of subjects: 168
Study 34898001 — intervention group
Group type: COMPARATOR
Intervention: Health education and rehabilitation training (control group)
Number of subjects: 168
Study 34446370 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin 10 mg daily
Number of subjects: 4304
Study 34446370 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4304
Study 33382771 — intervention group
Group type: EXPERIMENTAL
Intervention: Protection routine 1 (Avoidance of the sun during peak hours, use of shade, UV-index awareness, planning activities)
Number of subjects: 1548
Study 33382771 — intervention group
Group type: EXPERIMENTAL
Intervention: Protection routine 2 (Increased use of hat and sunscreen application routine)
Number of subjects: 1548
Study 33382771 — intervention group
Group type: COMPARATOR
Intervention: Minimal intervention control group
Number of subjects: 1548
Study 35947817 — intervention group
Group type: EXPERIMENTAL
Intervention: Ripretinib 150 mg once daily
Number of subjects: 453
Study 35947817 — intervention group
Group type: COMPARATOR
Intervention: Sunitinib 50 mg once daily (4 weeks on/2 weeks off)
Number of subjects: 453
Study 35947817 — intervention group
Group type: EXPERIMENTAL
Intervention: Ripretinib
Number of subjects: 453
Study 35947817 — intervention group
Group type: COMPARATOR
Intervention: Sunitinib
Number of subjects: 453
Study 33769420 — intervention group
Group type: EXPERIMENTAL
Intervention: Citizen responder activation
Number of subjects: 0
Study 33769420 — intervention group
Group type: EXPERIMENTAL
Intervention: Citizen responder systems
Number of subjects: 0
Study 33769420 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomized trial of citizen responder activation
Number of subjects: 0
Study 33769420 — intervention group
Group type: EXPERIMENTAL
Intervention: Observational studies
Number of subjects: 0
Study 36382669 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.025% capsaicin gel with topical anesthetic
Number of subjects: 24
Study 36382669 — intervention group
Group type: COMPARATOR
Intervention: Topical anesthetic monotherapy
Number of subjects: 24
Study 33321014 — intervention group
Group type: EXPERIMENTAL
Intervention: Balloon catheter
Number of subjects: 180
Study 33321014 — intervention group
Group type: COMPARATOR
Intervention: Basket catheter
Number of subjects: 180
Study 35356610 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided anterior serratus plane block
Number of subjects: 94
Study 35356610 — intervention group
Group type: COMPARATOR
Intervention: Brachial plexus block under ultrasound guidance
Number of subjects: 94
Study 34037975 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral sucrose solution (2 ml)
Number of subjects: 83
Study 34037975 — intervention group
Group type: COMPARATOR
Intervention: Placebo (2 ml)
Number of subjects: 83
Study 32144874 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard adherence support (counselling, two-way SMS, monthly adherence clubs)
Number of subjects: 67
Study 32144874 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard support plus drug-level feedback
Number of subjects: 67
Study 32144874 — intervention group
Group type: COMPARATOR
Intervention: Standard adherence support and drug-level feedback
Number of subjects: 67
Study 35796125 — intervention group
Group type: EXPERIMENTAL
Intervention: SN60WF group
Number of subjects: 181
Study 35796125 — intervention group
Group type: EXPERIMENTAL
Intervention: ZCB00 group
Number of subjects: 181
Study 35796125 — intervention group
Group type: EXPERIMENTAL
Intervention: AO group
Number of subjects: 181
Study 35796125 — intervention group
Group type: EXPERIMENTAL
Intervention: A1-UV group
Number of subjects: 181
Study 35796125 — intervention group
Group type: COMPARATOR
Intervention: All groups
Number of subjects: 181
Study 33938520 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 144
Study 33938520 — intervention group
Group type: COMPARATOR
Intervention: Amisulpride
Number of subjects: 144
Study 33938520 — intervention group
Group type: COMPARATOR
Intervention: Aripiprazole
Number of subjects: 144
Study 33938520 — intervention group
Group type: EXPERIMENTAL
Intervention: Antipsychotic-naive participants
Number of subjects: 144
Study 33938520 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants previously exposed to antipsychotics
Number of subjects: 144
Study 35920410 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical 10% lidocaine cream
Number of subjects: 40
Study 35920410 — intervention group
Group type: EXPERIMENTAL
Intervention: EMLA cream
Number of subjects: 40
Study 35920410 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% lidocaine cream
Number of subjects: 40
Study 32305061 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic parameters of fluid-responsiveness
Number of subjects: 0
Study 32305061 — intervention group
Group type: COMPARATOR
Intervention: Estimated oxygen extraction rate (O2ER)
Number of subjects: 0
Study 36207036 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile Vaani intervention
Number of subjects: 4800
Study 33638644 — intervention group
Group type: EXPERIMENTAL
Intervention: Feedback on quantity of antibiotic use (DDD, days-of-therapy)
Number of subjects: 4245
Study 33638644 — intervention group
Group type: EXPERIMENTAL
Intervention: Feedback on validated quality indicators
Number of subjects: 4245
Study 33638644 — intervention group
Group type: EXPERIMENTAL
Intervention: Feedback on non-validated quality indicators
Number of subjects: 4245
Study 33239474 — intervention group
Group type: EXPERIMENTAL
Intervention: Full intervention (behavior change package + 4 chickens)
Number of subjects: 260
Study 33239474 — intervention group
Group type: EXPERIMENTAL
Intervention: Partial intervention (behavior change package only)
Number of subjects: 260
Study 33239474 — intervention group
Group type: EXPERIMENTAL
Intervention: Full intervention
Number of subjects: 260
Study 33242835 — intervention group
Group type: EXPERIMENTAL
Intervention: Durvalumab therapy following chemoradiation
Number of subjects: 147
Study 33242835 — intervention group
Group type: COMPARATOR
Intervention: Chemoradiation alone (historical cohort)
Number of subjects: 147
Study 36375188 — intervention group
Group type: EXPERIMENTAL
Intervention: Septum-based double injection (DI group)
Number of subjects: 68
Study 36375188 — intervention group
Group type: COMPARATOR
Intervention: Single injection (SI group)
Number of subjects: 68
Study 36127497 — intervention group
Group type: EXPERIMENTAL
Intervention: SGLT2 inhibitor (SGLT2i) treatment for 12 weeks
Number of subjects: 68
Study 33492733 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-Rich Plasma (PRP)
Number of subjects: 17
Study 33492733 — intervention group
Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 17
Study 34931289 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative infusion of dexmedetomidine 0.4 μg·kg‐1·hr‐1
Number of subjects: 104
Study 34931289 — intervention group
Group type: COMPARATOR
Intervention: 0.9% saline (control)
Number of subjects: 104
Study 34931289 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative infusion of dexmedetomidine
Number of subjects: 104
Study 34606500 — intervention group
Group type: EXPERIMENTAL
Intervention: EmpaTeach intervention (empathy-building exercises and group work for teachers)
Number of subjects: 1493
Study 34606500 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 1493
Study 34606500 — intervention group
Group type: EXPERIMENTAL
Intervention: EmpaTeach intervention
Number of subjects: 1493
Study 32873686 — intervention group
Group type: EXPERIMENTAL
Intervention: TEXT4BP intervention (text messages containing information on hypertension, diet, medication and physical activity three times a week for 3 months)
Number of subjects: 200
Study 32873686 — intervention group
Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 200
Study 35962011 — intervention group
Group type: EXPERIMENTAL
Intervention: 80 Hz tACS
Number of subjects: 20
Study 35962011 — intervention group
Group type: COMPARATOR
Intervention: 40 Hz tACS
Number of subjects: 20
Study 35962011 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 20
Study 33564853 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental low-energy, low-protein formula (EF) supplemented with bovine MFGMs
Number of subjects: 0
Study 33564853 — intervention group
Group type: COMPARATOR
Intervention: Standard formula (SF)
Number of subjects: 0
Study 36109030 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based and mobile-based intervention (IMI) 'ACTonDiabetes'
Number of subjects: 210
Study 36109030 — intervention group
Group type: COMPARATOR
Intervention: Enhanced treatment as usual (TAU+)
Number of subjects: 210
Study 34130619 — intervention group
Group type: EXPERIMENTAL
Intervention: Gepotidacin (GSK2140944)
Number of subjects: 22
Study 35114409 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile financial incentives (CM) for abstinence
Number of subjects: 532
Study 35114409 — intervention group
Group type: COMPARATOR
Intervention: Standard care (SC)
Number of subjects: 532
Study 35114409 — intervention group
Group type: EXPERIMENTAL
Intervention: Cost-effectiveness of the interventions
Number of subjects: 532
Study 35114409 — intervention group
Group type: EXPERIMENTAL
Intervention: Potential treatment mechanisms (self-efficacy, motivation, treatment engagement)
Number of subjects: 532
Study 34467593 — intervention group
Group type: EXPERIMENTAL
Intervention: Vonafexor 400 mg once daily
Number of subjects: 73
Study 34467593 — intervention group
Group type: EXPERIMENTAL
Intervention: Vonafexor 200 mg twice daily
Number of subjects: 73
Study 34467593 — intervention group
Group type: EXPERIMENTAL
Intervention: Vonafexor/pegylated-IFN-?2a combination therapy
Number of subjects: 73
Study 34467593 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 73
Study 34467593 — intervention group
Group type: COMPARATOR
Intervention: Entecavir
Number of subjects: 73
Study 33837797 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiofrequency (RF) treatment consisting of three monthly sessions
Number of subjects: 117
Study 33837797 — intervention group
Group type: EXPERIMENTAL
Intervention: Pelvic floor muscle training (PFMT) consisting of 12 weekly sessions
Number of subjects: 117
Study 33837797 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of RF + PFMT
Number of subjects: 117
Study 33837797 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 117
Study 32785911 — intervention group
Group type: EXPERIMENTAL
Intervention: High-velocity resistance exercise (8 exercises using Thera-Band, 3 sets of 6 repetitions as fast as possible with moderate intensity)
Number of subjects: 14
Study 32785911 — intervention group
Group type: COMPARATOR
Intervention: Control session
Number of subjects: 14
Study 32835711 — intervention group
Group type: EXPERIMENTAL
Intervention: Liner applied (glass ionomer composite liner - Ionoseal, Voco)
Number of subjects: 30
Study 32835711 — intervention group
Group type: COMPARATOR
Intervention: No liner applied (control group)
Number of subjects: 30
Study 34231332 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple Single Cannulation Technique (MuST)
Number of subjects: 172
Study 34231332 — intervention group
Group type: EXPERIMENTAL
Intervention: Rope-Ladder Technique (RLC)
Number of subjects: 172
Study 34231332 — intervention group
Group type: COMPARATOR
Intervention: Buttonhole Technique (BHC)
Number of subjects: 172
Study 34798853 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg MPH + 10 mg escitalopram
Number of subjects: 20
Study 34798853 — intervention group
Group type: COMPARATOR
Intervention: Placebo + 10 mg escitalopram
Number of subjects: 20
Study 34798853 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (MPH + escitalopram and placebo + escitalopram)
Number of subjects: 20
Study 35809224 — intervention group
Group type: EXPERIMENTAL
Intervention: Synbiotic intervention
Number of subjects: 105
Study 34143831 — intervention group
Group type: EXPERIMENTAL
Intervention: Biological larviciding with Bacillus thuringiensis israelensis (full or guided intervention)
Number of subjects: 127
Study 34143831 — intervention group
Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 127
Study 33143794 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized depression risk information
Number of subjects: 712
Study 33143794 — intervention group
Group type: COMPARATOR
Intervention: Control group (no personalized depression risk information)
Number of subjects: 712
Study 35248830 — intervention group
Group type: EXPERIMENTAL
Intervention: Computerized multi-domain cognitive training (CT), 24 sessions over 8 weeks, 45 minutes each session
Number of subjects: 136
Study 35248830 — intervention group
Group type: EXPERIMENTAL
Intervention: Computerized multi-domain cognitive training (CT)
Number of subjects: 136
Study 35248830 — intervention group
Group type: COMPARATOR
Intervention: Active control intervention
Number of subjects: 136
Study 33218533 — intervention group
Group type: COMPARATOR
Intervention: Static stretching
Number of subjects: 33
Study 33218533 — intervention group
Group type: COMPARATOR
Intervention: Muscle energy technique stretching
Number of subjects: 33
Study 33218533 — intervention group
Group type: EXPERIMENTAL
Intervention: Vibration-assisted stretching
Number of subjects: 33
Study 33191288 — intervention group
Group type: EXPERIMENTAL
Intervention: Systemic sclerosis (SSc)
Number of subjects: 76
Study 33191288 — intervention group
Group type: COMPARATOR
Intervention: Non-SSc comparators
Number of subjects: 76
Study 32544561 — intervention group
Group type: EXPERIMENTAL
Intervention: Treat-and-extend (T&E) regimen
Number of subjects: 264